Distinct kinetics of effector CD8+ cytotoxic T cells after infection with Trypanosoma cruzi in naive or vaccinated mice.
about
Modulation of Cell Sialoglycophenotype: A Stylish Mechanism Adopted by Trypanosoma cruzi to Ensure Its Persistence in the Infected HostModulation of immune response in experimental Chagas diseaseTcTASV-C, a protein family in Trypanosoma cruzi that is predominantly trypomastigote-stage specific and secreted to the mediumA Human Trypanosome Suppresses CD8+ T Cell Priming by Dendritic Cells through the Induction of Immune Regulatory CD4+ Foxp3+ T CellsThe Combined Deficiency of Immunoproteasome Subunits Affects Both the Magnitude and Quality of Pathogen- and Genetic Vaccination-Induced CD8+ T Cell Responses to the Human Protozoan Parasite Trypanosoma cruziBradykinin B2 Receptors of dendritic cells, acting as sensors of kinins proteolytically released by Trypanosoma cruzi, are critical for the development of protective type-1 responsesCD8+ T-cells expressing interferon gamma or perforin play antagonistic roles in heart injury in experimental Trypanosoma cruzi-elicited cardiomyopathyModulation of CD4(+) T cell-dependent specific cytotoxic CD8(+) T cells differentiation and proliferation by the timing of increase in the pathogen load.Profile of central and effector memory T cells in the progression of chronic human chagas diseaseTrypanosoma cruzi subverts host cell sialylation and may compromise antigen-specific CD8+ T cell responses.Impaired innate immunity in Tlr4(-/-) mice but preserved CD8+ T cell responses against Trypanosoma cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-deficient mice.CD8(+) T cell-mediated immunity during Trypanosoma cruzi infection: a path for vaccine development?Subdominant/cryptic CD8 T cell epitopes contribute to resistance against experimental infection with a human protozoan parasite.Pathogen-induced proapoptotic phenotype and high CD95 (Fas) expression accompany a suboptimal CD8+ T-cell response: reversal by adenoviral vaccine.Recombinant yellow fever viruses elicit CD8+ T cell responses and protective immunity against Trypanosoma cruziVaccination using recombinants influenza and adenoviruses encoding amastigote surface protein-2 are highly effective on protection against Trypanosoma cruzi infectionBiological and immunological characterization of recombinant Yellow Fever 17D viruses expressing a Trypanosoma cruzi Amastigote Surface Protein-2 CD8+ T cell epitope at two distinct regions of the genomeLow frequency of circulating CD8+ T stem cell memory cells in chronic chagasic patients with severe forms of the disease.A human type 5 adenovirus-based Trypanosoma cruzi therapeutic vaccine re-programs immune response and reverses chronic cardiomyopathy.A Two-Component DNA-Prime/Protein-Boost Vaccination Strategy for Eliciting Long-Term, Protective T Cell Immunity against Trypanosoma cruziCostimulatory Effects of an Immunodominant Parasite Antigen Paradoxically Prevent Induction of Optimal CD8 T Cell Protective Immunity.CpG and interleukin-15 synergize to enhance IFN-γ production by activated CD8+ T cellsNovel protective antigens expressed by Trypanosoma cruzi amastigotes provide immunity to mice highly susceptible to Chagas' disease.DNA Vaccines against Protozoan Parasites: Advances and ChallengesA therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB/c mouse model of Chagas disease.CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance.Intrinsic role of FoxO3a in the development of CD8+ T cell memory.Chagas' disease: an update on immune mechanisms and therapeutic strategiesCD8+ T cells in Trypanosoma cruzi infection.Perforin and gamma interferon expression are required for CD4+ and CD8+ T-cell-dependent protective immunity against a human parasite, Trypanosoma cruzi, elicited by heterologous plasmid DNA prime-recombinant adenovirus 5 boost vaccination.Vaccination approaches against Trypanosoma cruzi infection.CD8(+) T Cell Responses to Plasmodium and Intracellular Parasites.The endless race between Trypanosoma cruzi and host immunity: lessons for and beyond Chagas disease.Chagas disease: still many unsolved issues.Antiparasitic Treatment Induces an Improved CD8+ T Cell Response in Chronic Chagasic Patients.LFA-1 Mediates Cytotoxicity and Tissue Migration of Specific CD8+ T Cells after Heterologous Prime-Boost Vaccination against Trypanosoma cruzi Infection.Protective immunity against Trypanosoma cruzi.Vaccination With Recombinant Filamentous fd Phages Against Parasite Infection Requires TLR9 Expression.Natural CD4+ T-cell responses against Trypanosoma cruzi KMP-11 protein in chronic chagasic patientsIL-17RA-Signaling Modulates CD8+ T Cell Survival and Exhaustion During Infection
P2860
Q26744674-6C23F0EF-AD66-45C3-9325-347F9389E40FQ27022885-643B7DEC-8BE6-4B1A-A815-7300E4BE990AQ27309739-F867C0AD-0654-46FE-8BD5-E1FBD339B073Q27313504-C8B507C2-6BB8-4DB5-B912-4269CA95F052Q27314524-0C0CE9EB-0FBD-4274-B7E2-D2FD902E91D2Q27319499-A32E44CF-DC45-4EE4-B606-4D458DE32972Q27346448-0677C796-0C57-4A22-AE9C-4AEB13AE9970Q33282864-783B4660-D47E-4524-AF31-DA8FA7F4CC85Q33501719-A9840503-5B2A-4E3D-9C4F-DBBEECB67769Q33809905-246ABE3C-6547-4D43-A647-703E49F009F5Q33818765-7C2CED81-5095-450B-A178-126087877276Q33914939-56A9ED39-1F4A-4C1E-8575-01BDEBA7FA7CQ33968196-42CD8861-0319-489F-9274-3BA9FB565C29Q34277020-FC8A4EA0-BAB9-4900-8F6A-C8B1083F59A5Q34635043-092B5E2D-9D07-4AEA-890B-3B412DDD1ACCQ34700649-1DE25AF5-938C-4C09-B94E-DE53896B181AQ34732681-7FCF43D8-69BB-4E5A-9596-80014294F8F5Q34874190-74BB45E9-D2EB-44EA-B14D-8CE2AF16FFE7Q35009081-1D099F73-3947-4B03-8A28-1E9B0FF86E4CQ35581314-837667FE-5FBC-4546-83E9-87D231CE7F93Q36136972-CBEECB69-E192-4E39-A1D3-5C853EE0B8B4Q36665239-3DAC1BD6-A032-4798-B654-DC1A3B8E81FCQ36844914-449A5B2A-F4A2-448D-AC25-877DC6D97173Q36915067-F5EB5F14-C47D-4CCA-A9DD-2DB693AA6189Q37130755-E45F8CAC-3010-4B3E-8457-CAFC61E21679Q37200211-20E880F9-336C-47E6-BCB1-EB687DA0CD05Q37273739-DAE57207-5D90-4F3F-AAB6-1BB88F44823BQ37310959-F783E6B0-8F39-4578-A0AF-57C2F7B77387Q37326239-642A9D6F-32F5-4C66-BBD2-DE4025F94761Q37355936-4A16066C-2288-4396-9E13-56C6F5FD4B72Q37524046-C9FA83C5-FA60-4C6E-9F4F-927B78EB3AB4Q37698282-92E95E6A-5480-44E5-A54F-7F16B4B4D9A2Q37788829-89F7CA67-F342-4A29-B514-687A87904942Q38238078-B79230F6-BA30-4D72-8D85-FE5E08D4D719Q40309242-EAE45944-3103-4C76-A1D0-A10E2485C322Q42682937-35CFA4ED-AAE4-4EA5-B78A-AE6302367851Q51890237-24BB3E0E-67D6-4DAF-849B-20CFC0B8A4FEQ55094740-3ADC0742-ED35-4EF9-9324-6FDEA86BA4D9Q57596977-D73930A7-D2FC-418C-AEF2-BCA5183E738AQ58572827-1F76C87A-4300-4DE1-B315-F0F5BA6CCF6F
P2860
Distinct kinetics of effector CD8+ cytotoxic T cells after infection with Trypanosoma cruzi in naive or vaccinated mice.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Distinct kinetics of effector ...... i in naive or vaccinated mice.
@en
Distinct kinetics of effector ...... i in naive or vaccinated mice.
@nl
type
label
Distinct kinetics of effector ...... i in naive or vaccinated mice.
@en
Distinct kinetics of effector ...... i in naive or vaccinated mice.
@nl
prefLabel
Distinct kinetics of effector ...... i in naive or vaccinated mice.
@en
Distinct kinetics of effector ...... i in naive or vaccinated mice.
@nl
P2093
P2860
P50
P1476
Distinct kinetics of effector ...... zi in naive or vaccinated mice
@en
P2093
Fanny Tzelepis
Marcus L O Penido
Mauricio M Rodrigues
P2860
P304
P356
10.1128/IAI.74.4.2477-2481.2006
P407
P577
2006-04-01T00:00:00Z